LIN-2002

N/A

Report date: 2022/01/05 15:24:33

Base Information

Drug NameLIN-2002
Drug Alias NameLIN-2002
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene modulators
TargetsComplement system proteins
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLinnuo (Shanghai) Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLinnuo (Shanghai) Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A